- Home
- COEP
as 07-26-2024 4:00pm EST
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | WEXFORD |
| Market Cap: | 10.2M | IPO Year: | N/A |
| Target Price: | $3.00 | AVG Volume (30 days): | 81.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.54 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.23 - $1.38 | Next Earning Date: | 08-09-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Coeptis Therapeutics Holdings Inc. News
COEP Breaking Stock News: Dive into COEP Ticker-Specific Updates for Smart Investing
PR Newswire
a month ago
Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering
MT Newswires
a month ago
--Ladenburg Downgrades Coeptis Therapeutics to Neutral From Buy
PR Newswire
2 months ago
Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting
PR Newswire
3 months ago
Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024
PR Newswire
3 months ago
Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
PR Newswire
4 months ago
Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor's Distinguished Research Award
Argus Research
4 months ago
Daily – Vickers Top Insider Picks for 03/21/2024
Argus Research
4 months ago
Daily – Vickers Top Insider Picks for 03/20/2024
Compare COEP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COEP Coeptis Therapeutics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.